Marie Selch Tvilum

Marie Selch Tvilum

Auto-generated profile, based on publicly available information

Marie Selch Tvilum

M. S. Tvilum, Assoc. Prof. T. Tørring, Department of Biological and Chemical Engineering, Aarhus University, Gustav Wieds Vej 10, 8000, Aarhus C, Denmark

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
MTMarie Tvilum
Marie Tvilum
MKMarianne Marquard Knap
Marianne Marquard Knap
LHLone Hoffmann
Lone Hoffmann
AKAzza Ahmed Khalil
Azza Ahmed Khalil
AAAne Appelt
Ane Appelt
DMDitte Sloth Møller
Ditte Sloth Møller
Background: The role of early treatment response for patients with locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemo-radiotherapy (cCRT) is unclear. The study aims to investigate the predictive value of response to induction chemotherapy (iCX) and the correlation with pattern of failure (PoF). Materials and methods: Patients with LA-NSCLC treated with cCRT were included for analyses (n = 276). Target delineations were registered from radiotherapy planning PET/CT to diagnostic PET/CT, in between which patients received iCX. Volume, sphericity, and SUVpeak were extracted from each scan. First site of failure was categorised as loco-regional (LR), distant (DM), or simultaneous LR+M (LR+M). Fine and Gray models for PoF were performed: a baseline model (including performance status (PS), stage, and histology), an image model for squamous cell carcinoma (SCC), and an image model for non-SCC. Parameters included PS, volume (VOL) of tumour, VOL of lymph nodes, Delta VOL, sphericity, SUVpeak, Delta SUVpeak, and oligometastatic disease. Results: Median follow-up was 7.6 years. SCC had higher sub-distribution hazard ratio (sHR) for LRF (sHR = 2.771 [1.577:4.87], p < 0.01) and decreased sHR for DM (sHR = 0.247 [0.125:0.485], p < 0.01). For both image models, high diagnostic SUVpeak increased risk of LRF (sHR = 1.059 [1.05:1.106], p < 0.01 for SCC, sHR = 1.12 [1.03:1.21], p < 0.01 for non-SCC). Patients with SCC and less decrease in VOL had higher sHR for DM (sHR = 1.025[1.001:1.048] pr. % increase, p = 0.038). Conclusion: Poor response in disease volume was correlated with higher sHR of DM for SCC, no other clear correlation of response and PoF was observed. Histology significantly correlated with PoF with SCC prone to LRF and non-SCC prone to DM as first site of failure. High SUVpeak at diagnosis increased the risk of LRF for both histologies.

23 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MTMarie S. Tvilum
Marie S. Tvilum
JVJonas L. Veiler
Jonas L. Veiler
TPThomas T. Paulsen
Thomas T. Paulsen
CKCarsten Kegler
Carsten Kegler
CNCamilla B. Nielsen
Camilla B. Nielsen
TTThomas Tørring
Thomas Tørring
The 4-amidopentadienoate (APD) motif is a rare and bioactive pharmacophore found in the cyclic lipodepsipeptide natural products BE-43547, rakicidins, microtermolides, and related compounds. Although several biosynthetic gene clusters associated with this family have been identified, the enzymatic origin of the APD warhead has remained unknown. Here, we investigated APD formation using NRPS engineering to install the unusual APD-associated polyketide synthase (PKS) module from the BE-43547 biosynthetic pathway into heterologous nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) assembly lines expressed in Escherichia coli . The engineered hybrids produced the designed lipopeptide containing the APD moiety, demonstrating that the core biosynthetic machinery is sufficient for APD installation and that no trans-acting enzymes are required. Total synthesis of the target compound enabled structural validation by co-elution, MS/MS analysis, and NMR spectroscopy. Production titers of 59 ± 13 μg L −1 were achieved in the heterologous host. Systematic mutagenesis further revealed that the conserved dehydratase His-Asp catalytic dyad is essential for APD formation, whereas an additional highly conserved histidine is dispensable. These findings establish the biosynthetic origin of the APD warhead and provide a foundation for incorporating this privileged pharmacophore into engineered peptide scaffolds.

20 February 2026 in Microbiology
Verified
Journal Article
Open access
MTMarie Selch Tvilum
Marie Selch Tvilum
CNCamilla Bak Nielsen
Camilla Bak Nielsen
ISIben Steensgaard
Iben Steensgaard
TPThomas Poulsen
Thomas Poulsen
MJMogens Johannsen
Mogens Johannsen
TTThomas Tørring
Thomas Tørring
The urgent need for new antibiotics emphasizes the importance of investigating the many biosynthetic gene clusters that remain silent under standard culture conditions and of assigning functions to the many natural products already discovered. Conventional approaches, such as altering the screening medium composition or culture conditions to trigger production, are often labourious and disconnected from the function of the natural products. In this study, we combine antimicrobial assays and the controlled culture conditions available in benchtop bioreactors to demonstrate that BE-43547, a natural product that exists as a mixture of congeners, is selectively active against Gram-positive bacteria growing anaerobically. Furthermore, we show that the producing organism Micromonospora sp. RV43 activates the biosynthesis of BE-43547 when cultured under low-oxygen conditions. These findings illustrate that linking compound function and regulation cues can provide a powerful strategy for discovering antibiotics with a new mode of action.